Related Experiment Videos
Screening for bioactive compounds targeting the cellular signal transduction pathway using an RT-PCR-based bioassay
1Faculty of Pharmaceutical Sciences, Science University of Tokyo, Japan.
Biological & Pharmaceutical Bulletin
|April 1, 1997
Summary
A new bioassay system using RT-PCR was developed to find compounds that affect gene expression. Coptidis Rhizoma extract was found to significantly enhance interleukin-2 gene expression in human T cells.
Area of Science:
- Molecular Biology
- Pharmacology
- Immunology
Background:
- Gene expression modulation is crucial for understanding cellular signaling pathways.
- Identifying bioactive compounds requires efficient screening methods.
- Interleukin-2 (IL-2) plays a vital role in immune responses.
Purpose of the Study:
- To establish a novel RT-PCR based bioassay for discovering compounds that modulate gene expression.
- To investigate the effect of traditional Chinese medicines on gene expression.
- To explore the impact of Coptidis Rhizoma on interleukin-2 gene expression.
Main Methods:
- Development of a quantitative RT-PCR bioassay using competitive PCR and internal standards.
- Application of the bioassay to screen crude drugs for bioactive compounds.
- Culturing Jurkat cells (a human T cell line) and treating them with extracts.
Main Results:
- The novel bioassay system successfully quantified changes in target mRNA levels.
- Screening identified Coptidis Rhizoma as a modulator of gene expression.
- The aqueous acetone extract of Coptidis Rhizoma enhanced interleukin-2 gene expression approximately 5-fold.
Conclusions:
- The developed RT-PCR bioassay is effective for discovering gene expression modulators.
- Coptidis Rhizoma extract shows potential for enhancing interleukin-2 expression.
- This approach provides tools to elucidate cellular signaling mechanisms.